Searched for
GENERIC ANTIDEPRESSANT TABLETS
Alembic Pharmaceuticals gets USFDA nod for generic antidepressant tabletsAlembic Pharmaceuticals has received final approval from the USFDA for its generic version of Brexpiprazole tablets, used in treating major...- Zydus gets US nod for schizophrenia generic medicineZydus Lifesciences has received the USFDA's final approval to produce a generic version of Paliperidone extended-release tablets, which are...
- Alembic Pharma gets USFDA nod for generic drug used to treat schizophreniaAlembic Pharmaceuticals has received final approval from the USFDA for its generic version of Paliperidone extended-release tablets, used t...
- Strides Pharma gets USFDA nod for antidepressant medicationAs per IMS, Fluoxetine tablets have a market size of USD 23.9 million. This approval further strengthens the company's presence in the Fluo...
- Alembic Pharma gets USFDA nod to market generic antidepressant drugThe company's product is therapeutically equivalent to Otsuka Pharmaceutical Co's reference listed drug product Rexulti tablets, it added. ...
- Granules India gets USFDA nod for generic antidepressant drug"We are pleased to receive approval of Bupropion Hydrochloride (XL) tablet product within first review cycle of 10 months from filing date....
- Lupin gains 1% on tentative USFDA nod to generic BrexpiprazoleAt 09:30 hours (IST), Lupin’s shares traded at Rs 957.70 on the National Stock Exchange, up 1.11% from previous close.
- Lupin gets tentative nod from USFDA to market generic Brexpiprazole tabletsThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Brexpiprazole tab...
- Aurobindo Pharma gets USFDA nod for generic antidepressant tabletsThe company has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine tablets i...
- Lupin launches generic antidepressant tablets in USThe company has launched its Fluoxetine tablets USP in the strength of 60mg after having received an approval from the United States Food a...
- Lupin launches generic drug to treat depression in USLupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded and generic formulations,...
- Glenmark Pharmaceuticals settles patent litigation over anti-depressant drugGlenmark Pharmaceuticals announced a patent litigation settlement with Forest Laboratories and Royalty Pharma Collection Trust over anti-de...
- Jubilant Life shares end nearly 9% up on USFDA nod for drugAt NSE, shares of the company soared 9.25 per cent to touch its one-year peak of Rs 452.50.
- Jubilant Life gets USFDA nod for generic anti-depressant tabletsThe final approval for abbreviated new drug application for Paroxetine tablets of Apotex is for strengths of 10 mg, 20 mg, 30 mg and 40 mg,...
- Jubilant receives USFDA approval for two generic drugsJubilant Life Sciences Ltd today said it has received approval from the USFDA to market generic versions of GlaxoSmithKline's anti-depressa...
- Aurobindo Pharma gets USFDA approval for anti-depressantAurobindo Pharma said it has received final approval from the US health regulator to manufacture generic version of Lexapro.
- Ranbaxy gets Australia nod for antipsychotic drugRanbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag’s anti-schizop...
- Aurobindo gets USFDA nod for anti-depressantDrug major Aurobindo Pharma on Wednesday said it has got tentative USFDA approval to market escitalopram oxalate tablets.
- Wyeth not to sue Sun Pharma over generic VenlafaxineSun Pharmaceutical Industries has received a covenant ‘not to sue’ from Wyeth over Sun Pharma’s abbreviated new drug application for generi...
- Lupin gets US nod for SertralineDomestic drug maker Lupin on Tuesday said USFDA has granted tentative approval for the company's Abbreviated New Drug Application (ANDA) fo...
Load More
